首页 | 本学科首页   官方微博 | 高级检索  
     

小儿肺炎支原体感染诊治研究进展
引用本文:崔亚利,陈丽珠,陈永传. 小儿肺炎支原体感染诊治研究进展[J]. 海南医学, 2016, 0(9): 1486-1488. DOI: 10.3969/j.issn.1003-6350.2016.09.038
作者姓名:崔亚利  陈丽珠  陈永传
作者单位:1. 北京丰台医院检验科,北京 丰台,100071;2. 三亚市中医院儿科,海南 三亚,572022;3. 北京善方医院检验科,北京 朝阳,100027
摘    要:肺炎支原体是小儿社区获得性肺炎的重要病原体,其感染以年长儿童为高发人群,不仅有呼吸道症状,常又有肺外损害的特征.血清学检测是诊断肺炎支原体感染的标准实验室手段,但PCR方法对于免疫损坏及年幼患儿肺炎支原体感染早期诊断更加适合,并且其应用前景也更加广阔.大环内酯类抗生素是小儿肺炎支原体感染的首选抗生素,但如何进行标准化治疗现今仍未达成共识.本文针对以上内容进行了概述.

关 键 词:肺炎支原体  儿童  诊断  治疗

Current progress of diagnosis and treatment in children with Mycoplasma pneumoniae infection
Abstract:Mycoplasma pneumoniae is an important pathogen of community-acquired pneumonia in children. It is characterized not only by the high incidence of respiratory symptoms in elderly children but also often by extra-pulmo-nary injuries. Serological testing is the standard laboratory method for the diagnosis of M. pneumoniae infection. Howev-er, PCR method is more applicable for younger and immunocompromised children with M. pneumonia infection, and its application prospect is broader. Macrolide antibiotics are the first choice in antibiotic treatment for children with M. pneumonia infection, but how to carry out standardized treatment still reaches no consensus. This article has reviewed the current progress of diagnosis and treatment in children with Mycoplasma pneumoniae infection.
Keywords:Mycoplasma pneumoniae  Childhood  Diagnosis  Treatment
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号